Dr. Daneil Kuftinec

Dr. Daneil Kuftinec

Medical Director of Global Medical Affairs

Medical Director of Global Medical Affairs

Lantheus

Dr. Daneil Kuftinec joined Lantheus in March 2022 from Lahey Hospital and Medical Center in Burlington, Massachusetts where she served as a board-certified Urologist in clinical practice for 15 years. She is member of the American Urological Association.

She received her medical degree from Tufts University. Dr. Kuftinec completed residencies at Boston University and its affiliated Boston Medical Center, Boston Children’s, and VA Boston Healthcare hospitals

Daneil lives in Carlisle , Massachusetts with her husband and two sons.

Dr. Jennifer Phillips

Dr. Jennifer Phillips

Group Medical Director

Group Medical Director

Johnson & Johnson

Jennifer Phillips, PhD, is a seasoned oncology leader with expertise in prostate cancer and a strong commitment to patient-centered care.   As Group Medical Director at J&J Innovative Medicine, she leads strategic initiatives that bridge clinical research, medical affairs, and patient advocacy. Her work focuses on advancing therapeutic innovation, improving patient outcomes, and fostering inclusive engagement across diverse communities.

Jennifer has actively participated in national forums where she has contributed to discussions on genetic testing, patient education, and health equity.

She collaborates closely with advocacy groups, professional societies and academic institutions to promote precision medicine and ensure that patient voices are central to clinical development and communication strategies.

She has a PhD in pharmacology from the University of Pennsylvania and has been involved in drug development including the approvals of Promacta, Arzerra, and Balversa.

Her personal journey, including the loss of both her grandfather and uncle to prostate cancer and her sister to colorectal cancer, fuels her passion for advancing oncology care and amplifying the impact of patient advocacy.

Jennifer’s leadership continues to shape meaningful partnerships and drive forward the mission of access and informed decision-making in prostate cancer treatment.

Dr. Stacey A. Kenfield

Dr. Stacey A. Kenfield

Associate Professor and Epidemiologist

Associate Professor and Epidemiologist

University of California, San Francisco

Stacey A. Kenfield, ScD,  is an epidemiologist, public health researcher, and professor at the University of California, San Francisco (UCSF) whose research looks at chronic disease prevention and survivorship. Kenfield’s research focuses on the association between modifiable behaviors (exercise, nutrition, and other lifestyle factors) and the risk of developing cancer as well as its progression after diagnosis. She seeks to identify opportunities to improve clinical and quality-of-life outcomes for patients diagnosed with cancer.

As part of the UCSF Urology and Epidemiology & Biostatistics departments, she has worked primarily on prostate cancer to gather evidence of the associations between lifestyle factors and the risk of lethal prostate cancer. She looks to translate the findings into behavioral interventions to improve cancer survivorship. She received the Prostate Cancer Foundation Young Investigator Award in 2012. Kenfield was appointed as the Helen Diller Family Chair in Population Science for Urological Cancer at UCSF in 2016 and the Associate Chair of Research in Urology at UCSF in 2022.

Kenfield has led large cohort studies with cancer patients to find the connections between lifestyle factors and cancer outcomes. She has also focused on digital health behavioral interventions among cancer patients and survivors. In particular, Kenfield is the principal investigator of two National Institutes of Health-funded randomized control trials examining the effects of exercise in men with metastatic castrate-resistant prostate cancer and the effects of digital health lifestyle interventions for men choosing radical prostatectomy.

She received her Bachelor of Science degree from the University of California at Los Angeles (UCLA) in Physiological Science in 2000, her Master of Science degree from the Harvard School of Public Health in Epidemiology in 2003, and her Doctorate of Science (Sc.D.) degree in 2006 from the Harvard School of Public Health. She resides in San Francisco, California.

Mr. William Thompson

Mr. William Thompson

Prostate Cancer Survivor & Cancer Nutrition Consultant, Executive & Entertainment Industry Health & Fitness Specialists

Prostate Cancer Survivor & Cancer Nutrition Consultant, Executive & Entertainment Industry Health & Fitness Specialists

Pro Trainer USA

William Thompson is a stage 4 prostate cancer survivor. He works as a Cancer Nutrition Consultant and a Health and Fitness Specialist for the executive/entertainment industry. Through his company Pro Trainer USA, he also works as a Master Fitness Trainer, Medical Exercise Specialist, and USA Olympic Committee Certified Sports Performance & Boxing Coach.

He attended UCLA where he studied Exercise Science & Kinesiology. He also attended The University of Arizona College of Medicine, Nutrition & Cancer program, where he received a certificate in Nutrition & Cancer. William Thompson has also been featured in Men’s Fitness magazine as one of the “Hollywood Top Trainers.” He resides in the Los Angeles, California area. And can be contacted at: www.ProTrainerUSA.com

Mr. Llewellyn ” Llew” Fambles

Mr. Llewellyn ” Llew” Fambles

Prostate Cancer Survivor

Prostate Cancer Survivor

Llewellyn “Llew” Fambles was diagnosed with prostate cancer in February of 2019. At the time it was slow-moving and slow growing. Llew is a retired IT executive who grew up in the East Texas towns of Big Sandy and Longview. Three of his four living maternal uncles have been diagnosed with prostate cancer as has his brother and four of his male cousins. Llew is scheduled to undergo robotic radical surgery on September 6th. It has been a learning journey for him even though there is such a deep history of prostate cancer in his family. He is hoping to understand why the African American male population is so disproportionately affected by prostate cancer. Is there something about the behavior, the diet, or the environment that impacts us so differently? He is divorced, the father of two children, and loves to travel. He is a graduate of The University of Texas at Austin and Prairie View A&M University.